Found: 54
Select item for more details and to access through your institution.
Susceptibility of Pseudomonas pseudomallei to new β-lactam and aminoglycoside antibiotics.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 1988, v. 21, n. 2, p. 171
- By:
- Publication type:
- Article
In-vitro susceptibility of Pseudomonas pseudomallei to DNA gyrase inhibitors.
- Published in:
- 1987
- By:
- Publication type:
- letter
Reduction of blood C-reactive protein concentration complements the resolution of sputum bacillary load in patients on anti-tuberculosis therapy.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.1005692
- By:
- Publication type:
- Article
Tuberculosis Molecular Bacterial Load Assay Reveals Early Delayed Bacterial Killing in Patients With Relapse.
- Published in:
- Clinical Infectious Diseases, 2023, v. 76, n. 3, p. e990, doi. 10.1093/cid/ciac445
- By:
- Publication type:
- Article
Rifampicin Resistance in Tuberculosis Outbreak, London, England.
- Published in:
- Emerging Infectious Diseases, 2005, v. 11, n. 6, p. 931, doi. 10.3201/eid1106.050118
- By:
- Publication type:
- Article
Genomic Investigations Unmask Mycoplasma amphoriforme, a New Respiratory Pathogen.
- Published in:
- Clinical Infectious Diseases, 2015, v. 60, n. 3, p. 381, doi. 10.1093/cid/ciu820
- By:
- Publication type:
- Article
Why Do We Use 600 mg of Rifampicin in Tuberculosis Treatment?
- Published in:
- Clinical Infectious Diseases, 2011, v. 52, n. 9, p. e194, doi. 10.1093/cid/cir184
- By:
- Publication type:
- Article
Toxicity related to standard TB therapy for pulmonary tuberculosis and treatment outcomes in the REMoxTB study according to HIV status.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Routine Use of Microbial Whole Genome Sequencing in Diagnostic and Public Health Microbiology.
- Published in:
- PLoS Pathogens, 2012, v. 8, n. 8, p. 1, doi. 10.1371/journal.ppat.1002824
- By:
- Publication type:
- Article
Combined quantitative tuberculosis biomarker model for time-to-positivity and colony forming unit to support tuberculosis drug development.
- Published in:
- Frontiers in Pharmacology, 2023, v. 14, p. 1, doi. 10.3389/fphar.2023.1067295
- By:
- Publication type:
- Article
Target product profiles: tests for tuberculosis treatment monitoring and optimization.
- Published in:
- Bulletin of the World Health Organization, 2023, v. 101, n. 11, p. 730, doi. 10.2471/BLT.23.290901
- By:
- Publication type:
- Article
PTPN22 and invasive bacterial disease.
- Published in:
- Nature Genetics, 2006, v. 38, n. 5, p. 499, doi. 10.1038/ng0506-499
- By:
- Publication type:
- Article
Bacterial etiology of urinary tract infections in patients treated at Kenyan health facilities and their resistance towards commonly used antibiotics.
- Published in:
- PLoS ONE, 2023, v. 17, n. 5, p. 1, doi. 10.1371/journal.pone.0277279
- By:
- Publication type:
- Article
Enhanced heterogeneity of rpoB in Mycobacterium tuberculosis found at low pH.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2009, v. 63, n. 6, p. 1118, doi. 10.1093/jac/dkp125
- By:
- Publication type:
- Article
Early bactericidal activity of a moxifloxacin and isoniazid combination in smear-positive pulmonary tuberculosis.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2005, v. 56, n. 6, p. 1169, doi. 10.1093/jac/dki376
- By:
- Publication type:
- Article
Effect of subinhibitory concentrations of ciprofloxacin on <it>Mycobacterium fortuitum</it> mutation rates.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2005, v. 56, n. 2, p. 344, doi. 10.1093/jac/dki191
- By:
- Publication type:
- Article
Analysis of rpoB and pncA mutations in the published literature: an insight into the role of oxidative stress in Mycobacterium tuberculosis evolution?
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2005, v. 55, n. 5, p. 674, doi. 10.1093/jac/dki069
- By:
- Publication type:
- Article
Mycobacterium tuberculosis Protocols. Methods in Molecular Medicine series.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2002, v. 49, n. 1, p. 226, doi. 10.1093/jac/49.1.226
- By:
- Publication type:
- Article
Mimicking in-vivo exposures to drug combinations in-vitro: anti-tuberculosis drugs in lung lesions and the hollow fiber model of infection.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-49556-5
- By:
- Publication type:
- Article
Identification of 2-Aminothiazole-4-Carboxylate Derivatives Active against Mycobacterium tuberculosis H<sub>37</sub>R<sub>v</sub> and the β-Ketoacyl-ACP Synthase mtFabH.
- Published in:
- PLoS ONE, 2009, v. 4, n. 5, p. 1, doi. 10.1371/journal.pone.0005617
- By:
- Publication type:
- Article
Studies of Early Bactericidal Activity: New Insights into Isnoniazid Pharmacokinetics.
- Published in:
- 2004
- By:
- Publication type:
- Editorial
A Step toward an Optimized Rifampin Dose Completed.
- Published in:
- 2015
- By:
- Publication type:
- letter
A Step toward an Optimized Rifampin Dose Completed.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2015, v. 192, n. 4, p. 525, doi. 10.1164/rccm.201506-1061le
- By:
- Publication type:
- Article
A Dose-Ranging Trial to Optimize the Dose of Rifampin in the Treatment of Tuberculosis.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2015, v. 191, n. 9, p. 1058, doi. 10.1164/rccm.201407-1264OC
- By:
- Publication type:
- Article
A dose escalating trial to optimize the dose of rifampin in the treatment of tuberculosis.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2015, v. 191, n. 9, p. E1, doi. 10.1164/rccm.201407-1264oc
- By:
- Publication type:
- Article
Profiling persistent tubercule bacilli from patient sputa during therapy predicts early drug efficacy.
- Published in:
- 2016
- By:
- Publication type:
- journal article
A new trial design to accelerate tuberculosis drug development: the Phase IIC Selection Trial with Extended Post-treatment follow-up (STEP).
- Published in:
- 2016
- By:
- Publication type:
- journal article
Erratum to: Limited role of culture conversion for decision-making in individual patient care and for advancing novel regimens to confirmatory clinical trials.
- Published in:
- 2016
- By:
- Publication type:
- corrected article
Limited role of culture conversion for decision-making in individual patient care and for advancing novel regimens to confirmatory clinical trials.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Editorial: Preserving antibiotics: stewardship and effective treatment in low and middle income countries.
- Published in:
- Frontiers in Antibiotics, 2024, p. 1, doi. 10.3389/frabi.2024.1432477
- By:
- Publication type:
- Article
Predominance of multidrug-resistant bacteria causing urinary tract infections among symptomatic patients in East Africa: a call for action.
- Published in:
- JAC-Antimicrobial Resistance, 2024, v. 6, n. 1, p. 1, doi. 10.1093/jacamr/dlae019
- By:
- Publication type:
- Article
Real-time monitoring of live mycobacteria with a microfluidic acoustic-Raman platform.
- Published in:
- Communications Biology, 2020, v. 3, n. 1, p. 1, doi. 10.1038/s42003-020-0915-3
- By:
- Publication type:
- Article
Perspectives for systems biology in the management of tuberculosis.
- Published in:
- European Respiratory Review, 2021, v. 30, n. 160, p. 1, doi. 10.1183/16000617.0377-2020
- By:
- Publication type:
- Article
Forecasting Clinical Dose–Response From Preclinical Studies in Tuberculosis Research: Translational Predictions With Rifampicin.
- Published in:
- Clinical Pharmacology & Therapeutics, 2018, v. 104, n. 6, p. 1208, doi. 10.1002/cpt.1102
- By:
- Publication type:
- Article
A Population Pharmacokinetic Model Incorporating Saturable Pharmacokinetics and Autoinduction for High Rifampicin Doses.
- Published in:
- Clinical Pharmacology & Therapeutics, 2018, v. 103, n. 4, p. 674, doi. 10.1002/cpt.778
- By:
- Publication type:
- Article
Implications of drug-induced phenotypical resistance: Is isoniazid radicalizing M. tuberculosis?
- Published in:
- Frontiers in Antibiotics, 2022, v. 1, p. 01, doi. 10.3389/frabi.2022.928365
- By:
- Publication type:
- Article
A simple label-free method reveals bacterial growth dynamics and antibiotic action in real-time.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-22671-6
- By:
- Publication type:
- Article
Perspective for Precision Medicine for Tuberculosis.
- Published in:
- Frontiers in Immunology, 2020, v. 11, p. N.PAG, doi. 10.3389/fimmu.2020.566608
- By:
- Publication type:
- Article
A comparison of liquid and solid culture for determining relapse and durable cure in phase III TB trials for new regimens.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Spot sputum samples are at least as good as early morning samples for identifying Mycobacterium tuberculosis.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Toxicity associated with tuberculosis chemotherapy in the REMoxTB study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Consideration of within-patient diversity highlights transmission pathways and antimicrobial resistance gene variability in vancomycin-resistant Enterococcus faecium.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2024, v. 79, n. 3, p. 656, doi. 10.1093/jac/dkae023
- By:
- Publication type:
- Article
Can phenotypic data complement our understanding of antimycobacterial effects for drug combinations?
- Published in:
- 2019
- By:
- Publication type:
- journal article
Improved power for TB Phase IIa trials using a model-based pharmacokinetic-pharmacodynamic approach compared with commonly used analysis methods.
- Published in:
- 2017
- By:
- Publication type:
- journal article
WGS accurately predicts antimicrobial resistance in Escherichia coli.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Early phase evaluation of SQ109 alone and in combination with rifampicin in pulmonary TB patients.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2015, v. 70, n. 5, p. 1558, doi. 10.1093/jac/dku553
- By:
- Publication type:
- Article
The relationship between Mycobacterium tuberculosis MGIT time to positivity and cfu in sputum samples demonstrates changing bacterial phenotypes potentially reflecting the impact of chemotherapy on critical sub-populations.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Greater Early Bactericidal Activity at Higher Rifampicin Doses Revealed by Modeling and Clinical Trial Simulations.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Innovative Trial Designs Are Practical Solutions for Improving the Treatment of Tuberculosis.
- Published in:
- Journal of Infectious Diseases, 2012, v. 205, n. suppl_2, p. S250, doi. 10.1093/infdis/jis041
- By:
- Publication type:
- Article
Strategies and Challenges Involved in the Discovery of New Chemical Entities During Early-Stage Tuberculosis Drug Discovery.
- Published in:
- Journal of Infectious Diseases, 2012, v. 205, n. suppl_2, p. S258, doi. 10.1093/infdis/jis191
- By:
- Publication type:
- Article